The rate of free-radical oxidation in rat heart with experimental hyperthyroidism (EH) was estimated after Melaxen and Valdoxan administration. It was found that the content of protein carbonyl groups increased if the pathology developed in cardiomyocytes. This indicated that they were oxidized. Increased concentrations of primary lipid peroxidation products (diene conjugates), inhibition of aconitate hydratase activity, and accumulation of citrate were noted. Injection of Melaxen and Valdoxan to rats with EH normalized these parameters. The melatonin-correcting capability of the used drugs and the antioxidant activity of melatonin probably facilitated normalization of free-radical homeostasis in rat cardiomyocytes with the pathology.
Similar content being viewed by others
References
A. Yu. Babenko, E. N. Grineva, and V. N. Solntsev, Klin. Eksp. Tireoidol., 9(1), 29 – 37 (2013).
F. Osman, J. Daykin, M. Sheppard, et al., J. Endocrinol., 164, 321 – 322 (2000).
M. Dorr, B. Wolff, D. M. Robinson, et al., J. Clin. Endocrinol. Metab., 90(2), 673 – 677 (2005).
C. Marcisz, G. Jonderko, T.Wroblewski, et al., Med. Sci. Monit., 12(11), 481 – 486 (2006).
L. Forst, P. Vestergaard, and L. Mosekilde, Arch. Intern. Med., 164, 1675 – 1678 (2004).
C. W. Siu, C. Y. Yeung, C. P. Lau, et al., Heart, 93, 483 – 487 (2007).
M. C. Soh and M. Croxson, Br. Med. J., 337, 531 (2008).
M. Marvisi, P. Zambrelli, M. Brianty, et al., J. Intern. Med., 17(4), 267 – 271 (2006).
G. Mintz, R. Pizzarello, and I. Klein, J. Clin. Endocrinol. Metab., 73, 146 – 150 (1991).
G. Loschen and L. Flohe, FEBS Lett., 18(2), 261 – 264 (1971).
M. S. Wolin, Arterioscler., Thromb., Vasc. Biol., 20(6), 1430 – 1442 (2000).
V. Kh. Khavinson, V. A. Barinov, A. V. Arutyunyan, et al., Free-Radical Oxidation and Aging [in Russian], Nauka, St. Petersburg (2003).
Yu. A. Vladimirov, Biokhimiya, 69(1), 5 – 7 (2004).
V. V. Lyakhovich, V. A. Vavilin, and N. K. Zenkov, Biokhimiya, 71(9), 1183 – 1197 (2006).
O. L. Belaya, V. A. Sulimov, I. G. Fomina, et al., Kardiovask. Ter. Profilaktika, No. 5, 21 – 27 (2006).
N. B. Perepech, Serdtse, No. 2, 64 – 68 (2007).
O. Makay, C. Yenisey, G. Icoz, et al., J. Endocrinol. Invest., 32(8), 641 – 646 (2009).
R. Martinez de Mena, T. S. Scanlan, and M. J. Obregon, Endocrinology, 151(10), 5074 – 5083 (2010).
N. P. Chesnokova, E. V. Ponukalina, and M. N. Bizenkova, Fundam. Issled., No. 4, 21 – 31 (2007).
E. P. Mottillo, X. J. Shen, and J. G. Granneman, Am. J. Physiol.: Endocrinol. Metab., 293, E1188-E1197 (2007).
L. V. Matasova and T. N. Popova, Biokhimiya, 73(9), 1189 – 1198 (2008).
A. Yu. Bespyatykh, V. Ya. Brodskii, O. V. Burlakova, et al., Melatonin: Theory and Practice [in Russian], S. I. Rapoport and V. A. Golichenkov (eds.), ID Medpraktika M, Moscow (2009).
Ya. I. Levin, Russ. Med. Zh., 16(26), 1732 – 1734 (2008).
S. W. Ying, B. Rusak, P. Delagrange, et al., Eur. J. Pharmacol., 296(1), 33 – 42 (1996).
V. Fernandez, K. Simizu, and S. B. M. Barros, Endocrinology, 129(1), 85 – 91 (1991).
E. E. Dubinina, S. O. Burmistrov, D. A. Khodov, and I. S. Porotov, Vopr. Med. Khim., 41(1), 24 – 26 (1995).
V. G. Afanas’ev, V. S. Zaitsev, and T. I. Vol’fson, Lab. Delo, No. 4, 115 – 116 (1973).
I. D. Stal’naya, Modern Methods in Biochemistry [in Russian], V. N. Orekhovich (ed.), Medtsina, Moscow (1972).
O. E. Kolesova, A. A. Markin, and T. N. Fedorova, Lab. Delo, 540 – 545 (1984).
O. I. Urazova, E. B. Kravets, V. V. Novitskii, et al., Byull. Sib. Med., No. 4, 47 – 52 (2008).
Yu. A. Vladimirov, Patol. Fiziol. Eksp. Ter., No. 4, 7 – 18 (1989).
L. E. Muravleva, V. B. Molotov-Luchanskii, D. A. Klyuev, et al., Fundam. Issled., No. 1, 74 – 78 (2010).
R. L. Levine, Free Radical Biol. Med., 32(9), 790 – 796 (2002).
M. K. Kale, K. P. Bhusari, and S. N. Umathe, J. Cell Tissue Res., 7(1), 871 – 876 (2007).
R. T. Dean, J. V. Hunt, and A. J. Grant, Free Radical Biol. Med., 11(12), 161 – 165 (1991).
J. Limson, T. Nyokong, and S. Daya, J. Pineal Res., 24(1), 15 – 21 (1998).
E. J. X. Costa, C. S. Shida, and M. H. Biaggy, FEBS Lett., 416, 103 – 106 (1997).
A. L. Bulteau, M. Ikeda-Saito, and L. I. Szweda, Biochemistry, 42(50), 14846 – 14855 (2003).
H. Raza, A. John, E. M. Brown, et al., Toxicol. Appl. Pharmacol., 226(2), 161 – 168 (2008).
Acknowledgments
The work was sponsored by the Russian Ministry of Education and Science under a state task to higher educational institutions for scientific activity in 2014 – 2016, Project No. 1090.
Author information
Authors and Affiliations
Additional information
Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 50, No. 8, pp. 7 – 11, August, 2016.
Rights and permissions
About this article
Cite this article
Popova, T.N., Agarkov, A.A., Gorbenko, M.V. et al. Effects of Melaxen and Valdoxan on Free-Radical Oxidation in Rat Heart with Experimental Hyperthyroidism. Pharm Chem J 50, 505–508 (2016). https://doi.org/10.1007/s11094-016-1477-z
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11094-016-1477-z